José Amauri SOARES,Eric CHETAILLE,Jessica NAKHLE,Fabien SCHMIDLIN
申请号：
US15557284
公开号：
US20180050030A1
申请日:
2016.02.16
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention concerns a combination comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and a PD-1 and/or PD-L1 inhibitor, for use as a medicament. It also concerns a pharmaceutical composition comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and PD-1 and/or PD-L1 inhibitor.
